-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 O7Q1waDHvO/gEaDuru1qSGrTI3JSKL+I76nz3b4PblsnCsY/FMYagKB78SZapQrs
 SBYhTB7Iu3AwQW6ypzU0Tg==

<SEC-DOCUMENT>0001193125-10-226428.txt : 20101008
<SEC-HEADER>0001193125-10-226428.hdr.sgml : 20101008
<ACCEPTANCE-DATETIME>20101008080050
ACCESSION NUMBER:		0001193125-10-226428
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20101008
DATE AS OF CHANGE:		20101008

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYTORI THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-157023
		FILM NUMBER:		101115048

	BUSINESS ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8584580900

	MAIL ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYTORI THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8584580900

	MAIL ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>dfwp.htm
<DESCRIPTION>FREE WRITING PROSPECTUS
<TEXT>
<HTML><HEAD>
<TITLE>Free Writing Prospectus</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Issuer Free Writing Prospectus dated&nbsp;October 8, 2010 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Filed Pursuant to Rule 433 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registration Nos.&nbsp;333-157023 and 333-169822 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Relating to the Preliminary Prospectus Supplement dated&nbsp;October 7, 2010 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>and the Prospectus dated February&nbsp;11, 2009) </B></FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g106604g54y57.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have filed registration statements (including a prospectus) and a preliminary prospectus supplement with the Securities
and Exchange Commission, or SEC, for the offering to which this communication relates. Before you invest, you should read the related prospectus and preliminary prospectus supplement as well as other documents we have filed with the SEC for more
complete information about us and this offering. You may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, we or the underwriter for this offering will arrange to send you the prospectus if you
request it from Equity Syndicate Prospectus Department, Jefferies&nbsp;&amp; Company, 520 Madison Avenue, 12th Floor, New York, NY, 10022, at 877-547-6340, and at Prospectus_Department@Jefferies.com. You may also access the preliminary prospectus
supplement by clicking on the following link: <U><A HREF="http://www.sec.gov/Archives/edgar/data/1095981/000119312510225853/d424b5.htm">http://www.sec.gov/Archives/edgar/data/1095981/000119312510225853/d424b5.htm</A></U>. The following information
supplements and updates the information contained in the prospectus and the preliminary prospectus supplement for this offering. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="75%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Issuer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cytori Therapeutics, Inc. (NASDAQ: CYTX)</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common stock offered by Cytori</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,000,000 shares of common stock. In addition, we have granted the underwriter an option for a period of 30 days to purchase up to an additional 600,000 shares of common stock to
cover overallotments. Except as otherwise indicated, all information in this issuer free writing prospectus assumes no exercise by the underwriter of its overallotment option.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon completion of this offering, we will have 49,909,194 shares of common stock outstanding based on 45,909,194 shares of common stock outstanding as of October 6, 2010, which
excludes as of that date:</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;7,072,177 shares of common stock issuable upon the exercise of outstanding stock options
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a weighted average exercise price of $5.19 per share, under our stock plans;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;11,774,104 shares of common stock reserved for issuance under various outstanding
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;warrant agreements with a weighted average exercise price of $3.81 per share (prior to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;giving effect to antidilution adjustments as a result of this offering);
and</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;1,340,885 shares of common stock reserved for future grant under our 2004 Equity
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive Plan.</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Public offering price</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$4.50 per share.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net proceeds to Cytori</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">We estimate that the net proceeds from the sale of the 4,000,000 shares of common stock that we are offering will be approximately $16.8&nbsp;million, or approximately $19.3
million if the underwriter exercises in full its option to purchase 600,000 additional shares of common stock, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pricing date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">October 8, 2010.</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="75%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Closing date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">October&nbsp;13, 2010.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dilution</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our net tangible book value as of June 30, 2010 was approximately $9.65 million, or $0.21 per share. After giving effect to the sale of 4,000,000 shares of our common stock in
this offering at the public offering price of $4.50 per share and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of June 30, 2010 would have been
approximately $26.4 million, or $0.53 per share. This represents an immediate increase in net tangible book value of $0.32 per share to existing stockholders and immediate dilution in net tangible book value of $3.97 per share to investors
purchasing our common stock in this offering at the public offering price.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the underwriter exercises in full its option to purchase 600,000 additional shares of common stock at the public offering price of $4.50 per share, the as adjusted net
tangible book value after this offering would be $0.57 per share, representing an increase in net tangible book value of $0.36 per share to existing stockholders and immediate dilution in net tangible book value of $3.93 per share to investors
purchasing our common stock in this offering at the public offering price.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">The above discussion is based on 45,900,581 shares outstanding as of June&nbsp;30, 2010, and excludes as of that date:</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;7,047,790 shares of common stock issuable upon the exercise of outstanding stock options
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a weighted average exercise price of $5.24 per share, under our stock plans;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;11,774,104 shares of common stock reserved for issuance under various outstanding
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;warrant agreements with a weighted average exercise price of $3.81 per share (prior to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;giving effect to antidilution adjustments as a result of this offering);
and</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;1,419,885 shares of common stock reserved for future grant under our 2004 Equity
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive Plan.</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sole book-running manager</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jefferies&nbsp;&amp; Company, Inc.</FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g106604g54y57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g106604g54y57.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X0"617AI9@``24DJ``@````#`#$!`@`>
M````,@```#(!`@`4````4````&F'!``!````9`````````!!9&]B92!0:&]T
M;W-H;W`@0U,S($UA8VEN=&]S:``R,#`Y.C`Q.C$S(#$S.C,T.C(X``,``:`#
M``$````!`/__`J`$``$```!%!0```Z`$``$````D`@```````/_B#%A)0T-?
M4%)/1DE,10`!`0``#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$`
M`&%C<W!-4T94`````$E%0R!S4D="```````````````!``#VU@`!`````-,M
M2%`@(```````````````````````````````````````````````````````
M````````$6-P<G0```%0````,V1E<V,```&$````;'=T<'0```'P````%&)K
M<'0```($````%')865H```(8````%&=865H```(L````%&)865H```)`````
M%&1M;F0```)4````<&1M9&0```+$````B'9U960```-,````AG9I97<```/4
M````)&QU;6D```/X````%&UE87,```0,````)'1E8V@```0P````#')44D,`
M``0\```(#&=44D,```0\```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I
M9VAT("AC*2`Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C````
M`````!)S4D="($E%0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y
M-C8M,BXQ````````````````````````````````````````````````````
M``````````````!865H@````````\U$``0````$6S%A96B``````````````
M````````6%E:(````````&^B```X]0```Y!865H@````````8ID``+>%```8
MVEA96B`````````DH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W
M=W<N:65C+F-H```````````````6245#(&AT='`Z+R]W=W<N:65C+F-H````
M`````````````````````````````````````````````````````````&1E
M<V,`````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@``````````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@````````````````````````````!D
M97-C`````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ```````````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0``````````````````````````````````
M=FEE=P``````$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````
M3`E6`%````!7'^=M96%S``````````$````````````````````````"CP``
M``)S:6<@`````$-25"!C=7)V````````!``````%``H`#P`4`!D`'@`C`"@`
M+0`R`#<`.P!``$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":
M`)\`I`"I`*X`L@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!
M$P$9`1\!)0$K`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I
M`;$!N0'!`<D!T0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"
M<0)Z`H0"C@*8`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:
M`V8#<@-^`XH#E@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$
M?@2,!)H$J`2V!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%
M!=4%Y07V!@8&%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'
M3P=A!W0'A@>9!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC[
M"1`))0DZ"4\)9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*
M\PL+"R(+.0M1"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-
M#28-0`U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/
M>@^6#[,/SP_L$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('
M$B8211)D$H02HQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4
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M$S5--8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV
M.G0ZLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_
MXD`C0&1`ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:
M1=Y&(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+
MXDPJ3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q
M4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9
M&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%
M8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUG
MDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>
M;WAOT7`K<(9PX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW
M5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$
M?^6`1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(
M:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_
MD:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:
MU9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16
MI,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVN
MH:\6KXNP`+!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1
MN4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#
MU,11Q,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZV
MSS?/N-`YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':
M=MK[VX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-
MYI;G'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_R
MC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<
M_VW____;`$,``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`@(!`0(!`0$"`@("`@("`@(!`@("`@("`@("`O_;`$,!`0$!`0$!`0$!`0(!
M`0$"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`O_``!$(`%(`R@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``````
M`````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q
M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C
MY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&
M!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R
M@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(
M24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JB
MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR
M\_3U]O?X^?K_V@`,`P$``A$#$0`_`/[^****`"BBOFKXV?MB_LP?LY@K\:?C
M9X%\"70#'^R]0U,WNM?+G(.B:1#<7:'CC=",UU8/`XW,:\<-@,'5QV)GM3HT
MYU9OTA!2D_N./'YCE^5X>6+S/'4<NPL='4KU84::;V3G4E&*;Z*Y]"ZMJVF:
M%IM[K&LWUMIFEZ=;R7=]?WDJ06UK;Q#<\LLKD!1V`ZDD``D@5^(/[3G_``5Q
M\5Z1K6H>`_V0/@U?_&#Q/:O-:MX@O]*US5---RA*$Z9H/A]1<7H$@.#)*H8'
MYD0\5R_QT_X*`?`K]M[QEX4_9P_9=^.7AKQ:FL7,<OBJUTJXU'1M?FC0"6Y6
M'2->LK2YNTCMF"H8HY%#M,S<K&R_KY\`OV>OA[\`/!^G^'_".@Z=:ZG]EA_M
MK6DMHCJ.H790&<->%=_V82%@J[OFQN?+$FOHO[.I<.QIU<_RRI4S"K=PPE93
MH\L4[<]:+BIZO:+5NY\Y_:5;B2=2EP_FE.GEM)+GQ=%PK<\FDU&C*+<-GK).
M_9]_Y2+'_@OQ^WM\"_C):>%_VGO@=X';PX]]8_V]X/U+P+XP^%GCK3-$NYX]
MVI:%>ZGJ<J7#BW=FC-S930RA"`ZD[A_7Q\,OB%X?^+'P]\&_$KPK)-)X>\;^
M'=,\1Z5]H01W,5MJ5LD_V:Z16(2ZBD9XI0"5$D+`$C!/\EO_``6OUO1OVQOV
MT_@5^SC\'-*B\9>,/"SV/AS7M6T6)+R8/=ZO=37^F+=PJ<VZW%_%;IEMGVB&
M9\^6`Y_JR^!'PTC^#GP:^&?POCF2X;P1X.T30;JXC),5QJ%K:(=3GA)`/DOJ
M#W3)GG:PSS7?Q5A\LCE628ZAE\,KS''IRG1@W;V=M)..B5WRN+LFU)IWM=>?
MPGBLTEFV>8"OF,\URW`-1A6FDW[1O6*E=MZ<RDKM+EBU92U]9HHHKX0^_"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***K7LLD%G=SQ)YDL-M/
M+&F,[Y(XG=$QWRR@?C32;:2W8FTDV]D?F/\`MM?M2>.]+U>U_9\_9^#3_$WQ
M+_H>J:U:EGET&*XQ&\=O)$";>5`X$DB_O#(?)CVLDF?E7PC_`,$.?A;\1+*3
MQ/\`M1_$'XA^+?&NNJUYJ5KX8UV'118W%P/,99=6N;*ZDNIU9CN556-2,`MU
MKV3]C_PVVO?M+>//'/BJ/[7K!U#4ELI[L>8\4ELUSRC.,JYN?+E_WR#UK1_X
M*6?\%:O@Q^PCX;O/!^BW=O\`$7]H[7;62T\)_#70V&HS:1?W46+/4/%"6Y)@
MVM(DD=G_`*Z4`-+Y$#+(_P"Q+%9[D6(R_A/@?FPN/Q%.G4Q6*I)*K5G/=RK-
M/V5"GY-)=[Z/\%IX#A_B>AF?''B%;&8##5:M+!8*K*3H4:=.UE&A%Q5:O5\T
M[ZMJR3C_`!X_&[]EC4?V-_\`@K=HOPN^!OBO7O$I\+?$WPUJW@;6G>-_$MI'
M/]CO$TK4;C388TNM1M[FZ6SD9(XUFD@(:)22E?VI_M,_&'X^_$B.?X,_LV>'
M[RTUS6+8:=XB\;21O#%I,=P@CO?LUR2%M(U#2!F#ARHY=%+`_C3_`,$N/V#_
M`(_^,?B1XC_X*5_MAZ7)8>)=6FN_%/PY\&:_%(VK3W&I22W,/BB]M9D#6UK"
M]T9[<R!3<W3I<(HBA1I?Z)_V:OB18>-[/Q;I\<-M'>Z'K#J\T,4:2W-K.S&(
MRN@!DV`IR>\I/>O2\3L^P>+Q.3TZ4J>>8SAJ@J>*Q6G)4Q=14E4NHZ24)4^;
ME348SJ2CHXR1S>$^09IAL-G6*QGM,AP?$]9/!X57YZ6"H.O*GRREK%SA7]FI
MM<TX48U+N,XGSG^P]_P3A^'?[*5S?_$GQ%,GC[X[^)A)/KGC?44%P=)>[1EN
M;31&F7*.8Y)(VGPN(W:&%41I&F_2RBBOQ7&X[%9CB)XK&5G6K3TN]DEM&*VC
M%=$M/F?O&!P&$RW#PPN#HJC1AK9;MO>4GO*3ZM^FR2"BBBN0[`HHHH`****`
M"BODGXE_MX?L?_!SQWJ?PR^)_P`?_`/@OQ]HS::NJ>%M:O;R+5+)M8L[:_TP
M3QQ63JIFL[RUD3#'*S+G%?6<4B31QS1,'CE1)(W'1T=0R,,]BI!_&NBMA<5A
MX4:E?#5*%/$+FIRG"48SC9.\'))25FG>-U9KNCFH8S!XFI7I8;%4\15PKY:L
M85(SE3E=KEJ1BVX.\9*TDG=-=&/HHHKG.D****`"BBB@`HHHH`****`"N>\3
M^*_#?@W2;C7/%6LZ=H>DVRDRWFHW,=O$3C/EQAVS-*1G"J"V`3C`)KY__:\_
M:O\`AM^QS\&M=^+OQ&NU:*T#V7ASP_%.D6H>)]?DADEM]-M=P8Q6ZI&TES/M
M80Q(<*\KQ12?B_\`LH>&OVE/^"HWB^;]H+X]:OJ/@G]G[3M59?!W@C3C-96N
MJ10.LL5G:6C/B11$T1FD<OLW@S/-.Q6OM,AX0JYAEF*XCS7%+*.&\%+DE7DK
MSKU?^?.&I[U)O9R^&.N[4DOS[B;CREE6<8/A3)<#+/>+,PCSQPT'RT\/2?\`
MR_Q=7:E!).2C\<E9OE4X2E[S^V%^U)\.?V5_@'\9?VA/AQJ;IJVL32:7\/9_
M(6$CQ%JEM<FXU&W1S_I-O;6=K)+'_#)<&&,Y5F-?!G_!#_\`X)^^%/C@-7_X
M*$?M+I_PM?Q[XK\2WMQX'M_%3?VSIUC>"2/4;G5KBWO2XO7A-W:B,2!DDN7F
M>16,";OK3_@O#^R9J7Q`_85T;P_\$]+M8M8^&_B1-5L/"4$T-M=>)M+DM(H[
M^"UEG=5O-51[6U:-'8;Q/(J88JI_#W_@F5^VO_P5#_9I^%5M^SMX`_9Z\5^*
M_#;:S>7OAVU\9_!/Q[=ZQX:NKY;:"\CTK6K1K6WNM-:2"-A'<BXCC=79'"NR
MG[?#QQ.8\)8K$Y%BOJN)QE;V4YUIJ%3ZO27*H>T2T;C:<K.WO35V]_B91PV6
M<787"9_AHXJC@:/MHTL/3<Z7UBM:?.J4GK%3;A&_6%-V2N?V<_M2?%GPU\)O
MA-X@OM:OH+>[U.RDT_2;'>BW%S(VW>8H2<E`H"`@??F0?3PC_@GWX+US3_`6
MO>/M?@FM9_&NH"33X)U9'%G"SO+)M8#Y,FVC_P"NEM*.U?(?P!_9"_:G_:)\
M6:7\8?VX=<NM*M;>:&_TWX<+)!#=J4.^*WGTVS=H='A0\!'RZ;OEC+'<O[:Z
M9IEAHVGV6DZ5:06&FZ=;0V=E9VR"."VMH$$<44:CHH4#KDD\DDDFOS7'/#9;
M@YY7A\1'%XBM)2K5(.]-6M:$)?:U6K6G0_4\`L5FF.AFV(PT\%AJ,7&A3J*U
M27-O4G'[-T]$_P#@EZO._B!\7OA3\*+2*^^)_P`2O`?P\M+A&>VF\:^+="\,
MK=*K;6-H-8OH3=88$'RPQ&#Z5\2?\%/OVVI_V)?V>)/$WA2.PO/BW\0M4D\&
M?"ZTU&);FQT_4S9R7FL>+M0LFXOK'2M."R+"QV37EY9PR@PR25_*7^SQ^Q#^
MV/\`\%,/%'BKXI0ZPNMV::S)9>*?C5\9-?U-],N-=>-+N;1=%\BSNKK5+B""
M>%GMK"W2SLDGBC9H"\<9];A[A"GF>7U<ZS?,XY-D]*7(JDDG*I)-)\J;BDDW
MRI^\Y23C&+LV>'Q/QO5RG,J.0Y+E4\\SNM%3E3BVHTHM77-92;DX^\U[L8P:
ME*:ND?VZ_#O]H'X%?%V>2U^%OQC^&/Q"O(ED>6P\'>./#?B'4(XXAF2233],
MU&29(@.2Q0+P>>*]8N;FWL[>>[NYX;6TM89;FZN;B5(;>WMX$:6:>>:1@L4*
M1JS,S$*JJ22`*_A[_:"_X)#_`+:_[(]GIOQ2\,C3_B79:/J6G;/%/P$OO$X\
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M(2.-G;"@FO5:_@_^,'AF]_X)K_\`!3B?5=#L#8^'_AC\7M*^(OA6.WC$0U+X
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M>ZF?&.GZ_I5[X5_LW3C.NH:A_P`)#;7;6GV&!K6Y$TWG>7$;>0.R[&Q_$W_P
M55^)&K_M=?\`!1+7?A[X-0Z[%X1U[PS^SG\/+.,+=13Z]!JPL=>EM@H(*R^/
M-:U:-G7AH=/C8DA0:_KTTG]F;PQH?[)$?[)FA7HT#PTOP1O/@W'K-A80W$EJ
MFI^%+CP[J/B)-/F=$N;R6\O+N]='91+-.VYAN)K3..&L-DN6Y!BL5C9?7,X2
MJ5*7(K4:5HMRNFY.24XJUE=J:Z&>1\5XK/LTXCPN#P$'@<D;ITZOM'>O63DE
M&S2BHMPF^92=HN#?Q'\;7_!5KQ7X6\8?\%$?BMXF\(^)=`\4^&[VY^%C6?B'
MPYK.G:YH=VMIX)\*P79MM6TRYEMYQ%/#,DFV0['B96PRD#^W'X<?%3X8?$2R
M6T^'_P`2/`7CJZTC3--DU:V\'>,/#WB>XTR.XA\NWDU"'1-1G:R222&94,@4
M,8F"Y*G'\!G[8_[,>F?LG_M.>,/V=-)\6WOC/3O"3^#88O%%_H]IHEY>_P#"
M4^'M&UN8R:59W4T4'DR:J\:[93O$(8[2Q`_KS_X)U_\`!,_PU^P5JOQ$\3Z#
M\5]:^(TGQ3T#PK875IJOA'2?#2:0NA7&IZA'+!-INISF\,C:LZD.%VB$$$[B
M!]KQWALG7#7#;693=3#89+!KV4O]I@XX92E-V_=-4U&=I6NWR[H^!\/,7GCX
MLXI4LJA&&+Q3>.?MH_[)-3Q4HP@K_ODZCE#FC=)+FV9^IE>?^/\`XL?"_P"%
M-A'JGQ.^(O@?X>Z=-N\B\\:>*M$\,P7)3[ZVKZQ>P_:7'=8]Q]J^>/V]/VJ;
M7]CC]F;QU\:%L+;5_$MJ;#PSX!T2\9UL]5\<^))7M-$CO_+8,VFVR)=WUTJ,
MKO;:5+&C*[JP_CB^"W[-?[8G_!5+XN^,_%\>N#Q?J]C<6]UX[^*GQ,U>[M?"
M7A4ZJ\SZ7H.F06MK</`/)@F^R:3I=KY<%O;;G6&/#M\=PUPE#.,'BLVS+,8Y
M3DV#ERRJR2;E/2\8IN*27-%<SNW*2C&,G>WW/%7&D\DQV$R7*LLEG.>8V//&
MC%M1A#WK2ERJ3;?+)\JLE&+G.48VO_<#\//VB/@)\6[IK#X7_&CX7?$'4$5W
M;3?"'CKPUK^I*D8W/(=.TW4I)Q$`"2WE[>.M>QU_"7^U9_P2V_:N_84T/3OC
M1?ZMX<\2^$M%U33$E^)?PBUC7K#5?`VKW=PD.DW6IV][8V6H:/;O?&*&*^MV
ME@6>:**62)I8@_\`1'_P1T_;P\5?M<_"/Q-X#^+-^NK?&+X+-HMIJ?B5Q'%=
M^.O!NM1W<7A_Q)J448"MX@AN=-O;/4)$55G:.WNF`EN90.C/>#L-@\K6>Y%F
ML<YRN$E"JU%1G2;:2;L]5S2BI)QA*/-%\KBVUS<.\<8K'9N^'N(<FED><3BY
MTDY.4*J2<FE=)I\L9.+4IPERS7-&45%_K]K6MZ-X;TG4->\1:OIF@Z'I-K+?
M:KK6M7]II>DZ990+NFO-0U&^ECALK5%Y:21U11R2*XWPA\8/A+\0;J^L?`7Q
M1^'7C>]TRS&H:E9^$/&WAKQ+=:?8&00B^OK?1M3G>TL_-(7S9`J;CMW9XKYN
M_P""CZJ_[!_[6"NJLI^"/C<%6`92/[,?@@]17\/O[*O@K]HOXK^-=:^`/[,T
MNJVVO_&G18M#\:VNC:@GAZSOO!6@WT>M7A\5^(8U#Z7X1ANQ;R7@5P+IO)MC
M'<-*D$BX9X/H<095F&8ULS67_4:BBW.*=-048SG.<G)-<L7)I;-I)RBFVGQ9
MQOB.&LXRW+*.4O,UF%-R2A)JJZCE*$*<(J,D^:2BF]6DVU&323_O3G_:V_9:
MM?$H\'7/[1GP0@\4&?[-_8<OQ1\%IJ`NL[?LK0G6?DNM_P`OEG#[OEV[N*^@
M8I8KB**>"6.:":-)89HG62*6*10\<L4B$B2-D8%6!((((.*_C5U__@W[_;!T
M>7PG#IOBKX)>*K37-9TS3?$TNCZOK=@W@G3[V:-+_P`075KX@T2U'B&PM(F=
MY(;-S=RF,+#`P)9?ZN_V:_@)X8_9D^"?@+X(^$=4U[7-&\#:.M@-:\2ZC=:E
MJVKW\TLEWJ>HS-<SR"P@EOYYVALX"MM9PE+:W01QC/!Q%E'#V6X?"5,GS_\`
MM>M6;4H*FDHJ*UFWS7A>6D82BW)7DI66OH\,9UQ/FN)QE+/.&_[%P]",7";J
M-N4I;047&T[1NY3C)*+2BXW>FYJ'QX^!VD>(9O".J_&;X4:9XLM]1BT>X\,:
MA\1/"%EXA@U:>2**#2YM%N=86YBU%Y9H52!HA*S2J`I+`'U>OX0OVLK>W;_@
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MABSF"-N2*_GT;3S+<Q\`$(T61GIV_2H\1^'F?\"\-Y!GN/QN38KASF<J.&HJ
MI'$3=U*<9<LJ=YW<N:;IN$ISC:2?,?D\N%/$OAKC[BGB7AS+L#GM/B>34:^*
MK\GU:DY0E&,X\T*O[J,(TG&G[2-2%*E+W7'D71:Y\8?%_P#P4>^*VE^#?A9H
M^IZ=\%_#5\D^J>(+^*6"UNK6*=&FN+I@,!9"D990<MLCACW/AG_;SPCX8TWP
M9X9T3PKI"LNG:%I\%A;E_P#62B)<RW$F./-DF:21L<;I3C`Q6'\-?A9\/_A!
MX8LO!WPW\*Z5X3\/6,:)%8Z7`(S*T:[!/>7#DRWMP1G+RNS<X!`XKOZ_,N(L
M^PV9+"Y?E.$>7Y%EMU0I2?-4E)_%5K26CJ2\FU%-I-W;/U7A/AC%Y/+&9KG>
M.6:\29M9XBM%.-*$5;EH4(NS5*%EJTG*R;BK)!1117RY]H?R>_\`!Q3KFHS?
M&#]FWPT\K_V3I_PV\9Z[;P9;RCJ.L>*+#3[N;;T,@M=#LESU`<CH:_<;_@EO
MX5T7PC^P'^S'9:);P0Q:M\.[7Q5J,D*(K7FM>*M0O]>U>[G=!^]G-Y?R)N;)
M"PJF<*`/S5_X."_V?-<\7?"WX3?M$>'=.GU"#X2ZGK7A+QX;6)Y9-.\*^-I=
M+ETC7;E44[-.MO$>EQV\TA.V,^((V.%#L///^"3?_!5GX$_#CX%>'OV;?VDO
M%B?#;4_AS)J-EX"\<:O:7\_A/7_">H:C<ZI9Z-J>I6%M,=$UNPN;ZZ@0W*I;
M36D<!2994>,_J^)PF)SCPXR6.54I8J>6UY^WI4TY33O6][DC>3:]I&5DFU&?
M-LFS\9PF-PF1^*>?SSBM'"0S3#T_J]:JU&#3CA[1YY644_93@FVES4^6]VD_
MZ::*_'G]IG_@M;^R#\%?#D4OPL\3VG[1?CJ[N;5+7POX!O)X-%L[)KB$WU]K
MOC.ZT]K.PVV1G,$,(NKB6=41XHHB\R?H)^S+^TU\)_VM/A3I'Q=^#^MOJOA^
M_EDT[5=.O(?LFN^%?$=K#;S:GX8\1V&YOL>KVPNH"P5GBECFCG@DEAECD;\]
MQ619Q@L%3S#%Y=5PV#JR<(SG!Q]Y*^L7:44_LRDE&=GRMV=OTW"<0Y'F&.JY
M;@<THXO&T8*<H4YJ?NMVNI1O&3CISJ,G*%X\R7,K_AE_P<)_L[?VIX2^$?[4
M&B6(:Z\*W\OPH\>S11@N^@>()+G6/!M_=%5SY-MKL6L6N]CC=XDA3/W17T%^
MPI^W+I^D?\$E]?\`BUXBU!+KQ5^RUX.\3_#F_AN9EDGO]8\.V=O#\*;>57.2
ME[8:YX0LU)SNDAEZE37ZG?M4?`_2_P!I']GCXN?!+5%B`\?>#-5TO2KF8+MT
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M?%5;[WJI>S3ZW5)4[I[2YC^&'_@K[_RDL^+_`/U]?"3_`-0/PC7]QVD_\@K3
M/^P?9?\`I-%7\.O_``6/AGTG_@I%\7;R^@FB@DM_A/JT+;"3<6">`_#(,\`_
MY:KYEI<(,'[\++U!K^PK]GS]JG]GG]HW3I+?X(_%CPG\1+WP_H.A:AX@TW0;
MQY-3T&VU6%XK$ZS83Q)+ITKS6MS'LD4,KV[J0"IKZ#C:A7J\,\$5Z5&52C0P
M:YYQBW&'-2PJCSR2M'F::5VKM61\UP%B,/2XNX_P]6O"E7Q&-?LX2E&,ZG+6
MQCER1;4I<J:;Y4[)IO1GY(_\'#5_<P_LQ?!?3XY&6UO_`(Z02W48)`E>Q\!^
M+VMMPZ,%:XD(]"!7I/\`P0,TG3[+]AW4]2MH(4OM;^-_C^XU*X5`)IWL=,\*
MZ=:),^,LL=K;($!)`$AQU-=-_P`%R?@SK_Q4_8FO?$?AG3KC5-0^#7CS0?B5
MJ5I:1M-<CPK%8:QX;\37D<*`M)':6>OQWD^!\EMIT\AX0U^6_P#P1E_X*0?!
M?]G#P9XP_9Z_:`\0KX#\.ZMXPN?'?@3Q]>6=[=^'8+[6--T[3M>\.^(I]/@E
MDTC=+H]C<6ER\9MF-U<)-+"5C,E83"XC-/#.6&RZG+$XC!XMRJ4X)RFXJ7-I
M!7E*T9PE9)Z1=OA(QN+PV3^+$<7FE:.$PN.P2A2J5'RTU)Q45><K1C>5.<;M
MI7DD_B/Z(?V]M(L-=_8J_:FTW4X(KBTD^!?Q'N3',H=5N=.\-7^HV,Z@CB:*
M^M+:6-NJR0JPP0#7\V__``;S7UQ%^U1\8;%';[-?_`2XGN(\G89;+Q[X0^SR
ME1P7475PH)Z"9@.M??7_``4U_P""K?[,MY^S9\1O@O\``;XB:5\6_B)\6_#M
MWX*FN_"2WEUX;\(>&];5;;Q%J^K:]+;);SW[Z.]W;VEK;/++Y]TLLWE11'?\
MY_\`!N]\&O$"^(/CW^T!>V%Q:^&'T'1OA+X<U":)T@UC57U6#Q3XI6QD88F2
MRBL/#B2LN0)-1,>=R.!>5X/%Y5X>\33S*C+!K&S@J4*J<)R=Z4;J$DI:O;2[
M4&]E<G-\=@\X\3.%(95B88UX"G-UITI*<(I*K-Q<XMKW8[J]DYI/WFT?MW_P
M4=_Y,0_:O_[(EXW_`/39)7\]W_!N_:VTG[1_QYO)((GNK7X)Z=#;7#(IE@BN
M_'.D-=)$Y&460VMONQU\E<]*_H1_X*._\F(?M7_]D2\;_P#ILDK^?7_@W<_Y
M.'_:`_[(QHW_`*G%A7-P\VO#OBZSM^\A_P"X#KXF_P"3F<%_]>I_G7/ZWZ**
M*_,#]:/X2/VL?^4M_C[_`+.]\#?^I5X.K^[>OX2/VL?^4M_C[_L[WP-_ZE7@
MZO[MZ_3_`!#_`-PX-_[`5_Z;PY^2^&?_`",N.O\`L/?_`*<Q`4445^8'ZT%%
M%%`!1110!C^(?#VA>+-"UCPQXGTC3M?\.^(--O-'US1-7M(;_3-6TO4('MKV
MPO[.X1DN;66WD='1@0RL017\]7[0'_!OA\,_%GB'4O$7[/'Q@U/X466HW,ET
MO@'Q?H4GC;PQI;3,SM;:%K,.J6NHV&G*3B.&Y:^:-0%$VT`#^BVBO8RC/\WR
M*I.IE>-EAO:VYHVC*$K;<T)J46UT=KJ[LU=GAYWPWDO$-.G3S?`1Q?L;\DKR
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M7+Z-XHCTFYN-$O6TRQLE06Y6:(CS8BDC!Z\__P"")?\`P3W^*/@CX@ZA^UG\
M=O!VL>"/L/A_4M"^$GACQ;93:?XJO[_Q+&D.O^.M2TF^47.DVBZ,US9V8N4C
MN+DZQ<S[%CCC:;[WA6C_`*J9'F/%&*QM)5<QPW)A*49MSE-R;7/!J-VIQ@_=
MYN6'/)M(_..+\3_KEQ#EG".#P-9TLLQ7/C:\H)0C!17-R33=HNG*>LN3FJ.G
M%)L_I2\+>&M&\&>&?#O@_P`.V<>G^'_"NAZ3X<T.PB`$=EI&B6$&FZ=:H`!\
ML=G;0J./X:WJ**_)Y2E*4I2;E*3;;>K;>[?FS]FC&,(QA%*,8I));)+1)>21
M^9G[?7_!,#X0_MV2Z%XLU/Q#J_PQ^+/AG3&T/3O'^@:?9ZO#JWA\3SWEOH7B
MO0+R:%=7M8+RXN)+6:.XM[FW^US*))(G$2\A_P`$W?\`@F;?_L">(_BKKUY\
M8+7XGK\2=&\,:3';6_@N3PHVD'P[?ZO>&=Y7\17WVWS1J@7:%CV>3G+;L#]8
MJ*]I<1YTLIGD;QSEE<[+V4HPE9*2FE&<HNI&*DDTHR26UK-G@OA;(7G4.(%E
M\89O!M^UC*I&[<'!RE",E3E)P;3E*#;W;NDU7N[2UO[6YL;ZVM[RRO;>:TO+
M.[ACN+6[M;B-H;BVN;>92D]O)$[JZ,"K*Y5@02*_GV_:8_X("?"?XB>*-5\8
M_L\_$RZ^";:Q=37UUX`UGP^?%O@2SNKB1Y9QX;D@U*TOO#MAO;*VA>\@BSM@
M$,06,?T(T5EE.>YKD=:=;*\9+"RJ)*:M&4)I;<T)J47;6S:NKNS5S;.N'LFX
MAHPH9O@8XN%)MP=Y0G!NU^2I!QG%.RYDI<LK+F3LC^9/X1_\&[-C9^(+._\`
MCI^T/)K_`(;M;B*6Y\,?#+PG+X>O-7A1@TEI/XHU_4KIM,A=059H+)I0&.R2
M-L,/Z+_AA\+_``#\&/`?AOX9?##PQIO@_P`#^$M/33=!T#2HFCMK2W5FDEED
MDD9I+R]FN))9;BXF>2>XFF>::1Y'9CWM%;9QQ)G6?.G_`&IC7B(4G>,%&,()
M[7Y(1C%RM=<S3E9M7LS#(^%<AX<51Y1@(X:I65I5'*=2I)7ORN=24I*-[/E3
M46TFU?4\0_:4^$$OQ_\`@'\6_@I!KR>%YOB=X'USP='XBDT\ZK'HS:Q:M;"_
M;35NX#>B/=GRQ-'NQC>*_/'_`()Q_P#!+;4?V"OB-\0O'E[\:+7XG)XY\%67
MA%-,M_`\GA5M-:TUVWUDW[73^);[[4&$!C\O8F-V[><8K]?:*PPV=9EA,MQF
M4T,1R8#'M2JPY(/F:Y;>\XN<?AC\,EMYLZL5D.5XS-,#G.)PWM,QRY.-&ISU
M%R)\U_<C)0E\4OBB]_)!1117E'KGX)?%S_@BKJWQ/_:^\0_M21?M#V.C6^N?
M&+0OBHO@M_AO-?2VT>BZKHVIG13K@\81B5Y!I)3S_LH"^?N\H[<'][:**]7,
M<ZS+-J>"I8_$>WAEU/V=%<D(\L+15KPC%RTA'65WIOJSQ\KR'*\FJX^MEV&=
M"IF=3VM=\]2?/.\GS6G*2CK.3M'E6NVBL4445Y1[`4444`%%%%`!1110`444
D4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
